Literature DB >> 23740875

Submaximal heart and pulmonary evaluation: a novel noninvasive test to identify pulmonary hypertension in patients with systemic sclerosis.

Elana J Bernstein1, Lisa A Mandl, Jessica K Gordon, Robert F Spiera, Evelyn M Horn.   

Abstract

OBJECTIVE: Pulmonary hypertension (PH) is a leading cause of death in patients with systemic sclerosis (SSc; scleroderma). Although right-sided heart catheterization (RHC) is the gold standard for diagnosing PH, it is an invasive test with associated risks. The submaximal heart and pulmonary evaluation (step test) is a noninvasive, submaximal stress test that could be used to identify patients with PH. The purpose of this study is to assess the correlation between change in end tidal carbon dioxidePETCO2 ) from rest to end-exercise on the step test and mean pulmonary artery pressure (mPAP) on RHC in SSc patients.
METHODS: This is a retrospective cohort study of patients with limited or diffuse cutaneous SSc who were evaluated in an academic cardiology practice between November 2007 and November 2011 and underwent a step test and RHC. Statistical analysis was performed using Spearman's correlation test and multivariable linear regression.
RESULTS: A total of 679 charts were reviewed. Nineteen SSc patients who underwent a step test and RHC were included. ΔPETCO2 was negatively correlated with mPAP (r = -0.82, P < 0.0001). In a multivariable linear regression model evaluating the relationship between ΔPETCO2 and mPAP, controlling for age, sex, and time between and order of step test and RHC, ΔPETCO2 remained the only variable statistically significantly associated with mPAP (P < 0.001). The step test had a sensitivity of 100%, specificity of 75%, positive predictive value of 93.8%, and negative predictive value of 100% for the diagnosis of PH.
CONCLUSION: ΔPETCO2 on the step test has a strong, statistically significant negative correlation with mPAP on RHC.
Copyright © 2013 by the American College of Rheumatology.

Entities:  

Mesh:

Year:  2013        PMID: 23740875      PMCID: PMC4084928          DOI: 10.1002/acr.22051

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  12 in total

1.  Changes in causes of death in systemic sclerosis, 1972-2002.

Authors:  Virginia D Steen; Thomas A Medsger
Journal:  Ann Rheum Dis       Date:  2007-02-28       Impact factor: 19.103

2.  Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study.

Authors:  Eric Hachulla; Virginie Gressin; Loïc Guillevin; Patrick Carpentier; Elisabeth Diot; Jean Sibilia; André Kahan; Jean Cabane; Camille Francès; David Launay; Luc Mouthon; Yannick Allanore; Kiet Phong Tiev; Pierre Clerson; Pascal de Groote; Marc Humbert
Journal:  Arthritis Rheum       Date:  2005-12

3.  Echocardiographic features of primary pulmonary hypertension.

Authors:  E Bossone; T H Duong-Wagner; G Paciocco; H Oral; M Ricciardi; D S Bach; M Rubenfire; W F Armstrong
Journal:  J Am Soc Echocardiogr       Date:  1999-08       Impact factor: 5.251

Review 4.  Pulmonary hypertension in systemic sclerosis and systemic lupus erythematosus.

Authors:  S R Johnson; J T Granton
Journal:  Eur Respir Rev       Date:  2011-12

5.  End-tidal CO2 pressure decreases during exercise in cardiac patients: association with severity of heart failure and cardiac output reserve.

Authors:  A Matsumoto; H Itoh; Y Eto; T Kobayashi; M Kato; M Omata; H Watanabe; K Kato; S Momomura
Journal:  J Am Coll Cardiol       Date:  2000-07       Impact factor: 24.094

6.  Clinical evaluation of pulmonary hypertension in systemic sclerosis and related disorders. A Doppler echocardiographic study of 135 Japanese patients.

Authors:  I Murata; K Takenaka; S Yoshinoya; K Kikuchi; T Kiuchi; T Tanigawa; K Ito
Journal:  Chest       Date:  1997-01       Impact factor: 9.410

7.  Ventilatory expired gas at constant-rate low-intensity exercise predicts adverse events and is related to neurohormonal markers in patients with heart failure.

Authors:  Ross Arena; Dean MacCarter; Thomas P Olson; Sophie Lalande; Maile L Ceridon; Lyle J Olson; Bruce Johnson
Journal:  J Card Fail       Date:  2009-02-10       Impact factor: 5.712

8.  Comparison of Doppler derived haemodynamic variables and simultaneous high fidelity pressure measurements in severe pulmonary hypertension.

Authors:  S J Brecker; J S Gibbs; K M Fox; M H Yacoub; D G Gibson
Journal:  Br Heart J       Date:  1994-10

9.  Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach.

Authors:  D Mukerjee; D St George; B Coleiro; C Knight; C P Denton; J Davar; C M Black; J G Coghlan
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

10.  Developing pulmonary vasculopathy in systemic sclerosis, detected with non-invasive cardiopulmonary exercise testing.

Authors:  Daniel Dumitrescu; Ronald J Oudiz; George Karpouzas; Arsen Hovanesyan; Amali Jayasinghe; James E Hansen; Stephan Rosenkranz; Karlman Wasserman
Journal:  PLoS One       Date:  2010-12-13       Impact factor: 3.240

View more
  2 in total

1.  Pulmonary Arterial Hypertension: Diagnosis, Treatment, and Novel Advances.

Authors:  Bradley A Maron; Steven H Abman; C Greg Elliott; Robert P Frantz; Rachel K Hopper; Evelyn M Horn; Mark R Nicolls; Oksana A Shlobin; Sanjiv J Shah; Gabor Kovacs; Horst Olschewski; Erika B Rosenzweig
Journal:  Am J Respir Crit Care Med       Date:  2021-06-15       Impact factor: 30.528

2.  Diagnostic utility of sub-maximum cardiopulmonary exercise testing in the ambulatory setting for heart failure with preserved ejection fraction.

Authors:  Hannah T Oakland; Phillip Joseph; Ahmed Elassal; Marjorie Cullinan; Paul M Heerdt; Inderjit Singh
Journal:  Pulm Circ       Date:  2020-11-25       Impact factor: 3.017

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.